Loading...

Home
ETF
SILO

SILO

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

SILO News

Silo Pharma Authorizes $1 Million Share Repurchase Program

Feb 24 2026NASDAQ.COM

Keysight Technologies Quarterly Earnings Beat Estimates

Feb 24 2026Benzinga

Silo Pharma Approves $1M Share Buyback Program

Feb 23 2026seekingalpha

SILO PHARMA SECURES NOTICE OF ALLOWANCE IN JAPAN FOR SPC-15, ENHANCING GLOBAL INTELLECTUAL PROPERTY ASSETS

Feb 18 2026moomoo

Silo Pharma Partners with Allucent to Advance SPC-15 Clinical Studies

Dec 30 2025Globenewswire

Silo Pharma Enters LOI with Allucent for SPC-15 Clinical Studies

Dec 30 2025Newsfilter

Silo Pharma Collaborates with Allucent to Assist in Upcoming FDA Investigational New Drug Application for SPC-15 as a PTSD Treatment

Nov 17 2025Newsfilter

Silo Pharma Provides Update on Progress in PTSD Drug Development and Launches New Digital Assets Treasury Initiative

Oct 23 2025Newsfilter

Silo Pharma Completes $2.5 Million Registered Direct Offering at Market Price in Compliance with Nasdaq Regulations

Oct 01 2025Newsfilter

Silo Pharma Unveils $2.5 Million Registered Direct Offering Priced According to Nasdaq Regulations

Sep 30 2025Newsfilter

Silo Pharma Enhances Strategic Partnership with Fireblocks for Secure Management of Crypto Treasury

Sep 29 2025Newsfilter

Silo Pharma Collaborates with Fireblocks to Enhance Crypto Treasury Strategy and Security Measures

Sep 23 2025Benzinga

EXCLUSIVE: Hoth Therapeutics' Antisense Treatment Shows Effectiveness in Targeting KIT-Driven Cancers

Sep 02 2025Benzinga

Silo Pharma's Alzheimer's Treatment SPC-14 Highlighted in Prestigious Scientific Journal

Aug 21 2025Newsfilter

Silo Pharma's SPC-15 for PTSD Reaches Key Safety Milestone, Clearing Path for Faster Clinical Trials via 505(b)(2) Pathway

Aug 19 2025Newsfilter

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

Jul 16 2025Newsfilter